In 2008年

On October 17,  Farmasino Pharmaceuticals Co., Ltd was formally established;

In October, the production center was established, Anhui Sino Pharmaceutical Co., Ltd;

In 2009年

In 2009, the first year of its establishment, Farmasino Co., Ltd's sales exceeded 200 million yuan;

In 2016年

Farmasino Co., Ltd's annual sales exceeded 1 billion yuan; On January 29, Skyrun Pharma Co., Ltd was established; On December 20, Jiangsu Zonta Pharmaceuticals Co., Ltd was established;

In 2017年

Farmasino Co., Ltd was elected as the vice president unit of China Medical Insurance Chamber of Commerce and selected as a key cultivation in Jiangsu Province

and develop internationally renowned brands;

In 2021年

In August, FarmaSino Pharmaceuticals (Anhui) Co., Ltd was established to build a large-scale APIs and intermediates production base;

In December, Skyrun Pharma was recognized as a High Technology Expertise；

In 2022年

In August, Farmasino Co., Ltd was approved by the CNAS;

On December 31, the sales of Farmasino Co., Ltd exceeded 200 million US dollars;

In 2023年

In November, Skyrun Pharma Co., Ltd was rated as a gazelle enterprise；

In 2024年

In May，Skyrun Pharma Co., Ltd was identified as the new special expertise enterprise;